Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Total Liabilities (2023 - 2024)

Historic Total Liabilities for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $13.2 billion.

  • Universe Pharmaceuticals' Total Liabilities fell 9994.13% to $13.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 billion, marking a year-over-year decrease of 9994.13%. This contributed to the annual value of $13.2 billion for FY2025, which is 9994.13% down from last year.
  • Per Universe Pharmaceuticals' latest filing, its Total Liabilities stood at $13.2 billion for Q3 2025, which was down 9994.13% from $22450.5 billion recorded in Q3 2024.
  • Universe Pharmaceuticals' Total Liabilities' 5-year high stood at $22450.5 billion during Q3 2024, with a 5-year trough of -$35.3 billion in Q3 2022.
  • Over the past 5 years, Universe Pharmaceuticals' median Total Liabilities value was $22.9 million (recorded in 2021), while the average stood at $3738.1 billion.
  • As far as peak fluctuations go, Universe Pharmaceuticals' Total Liabilities crashed by 15244221.26% in 2022, and later soared by 16322452549.79% in 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Total Liabilities (Quarter) stood at $23.2 million in 2021, then crashed by 152442.21% to -$35.3 billion in 2022, then skyrocketed by 100.04% to $13.8 million in 2023, then soared by 163224525.5% to $22450.5 billion in 2024, then plummeted by 99.94% to $13.2 billion in 2025.
  • Its last three reported values are $13.2 billion in Q3 2025, $22450.5 billion for Q3 2024, and $22.7 million during Q1 2024.